Home
ONCO
ONCO News

Latest Onconetix Inc. (ONCO) News on May 18, 2025

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

GlobeNewswire

17 days ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.

GlobeNewswire

a month ago

Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.

Onconetix claims validation of prostate cancer test Proclarix in Danish cohort

TipRanks

2 months ago

Onconetix claims validation of prostate cancer test Proclarix in Danish cohort

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

GlobeNewswire

2 months ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

GlobeNewswire

2 months ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

GlobeNewswire

5 months ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

GlobeNewswire

7 months ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

GlobeNewswire

7 months ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

GlobeNewswire

8 months ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

GlobeNewswire

10 months ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

GlobeNewswire

10 months ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

GlobeNewswire

a year ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS

PR Newswire

a year ago

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS

Jet.AI to Participate in A.G.P.’s Virtual Technology Conference

GlobeNewswire

a year ago

Jet.AI to Participate in A.G.P.’s Virtual Technology Conference

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024

GlobeNewswire

a year ago

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

GlobeNewswire

a year ago

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

ACCESSWIRE

a year ago

WidePoint Awarded More than $70.3 Million in IT and Security Services Contracts During Q4 2023

Celebrating 20 Years of Cutting-Edge Onboard Broadcasting and Technical Innovation: Vislink and MotoGP™

GlobeNewswire

a year ago

Celebrating 20 Years of Cutting-Edge Onboard Broadcasting and Technical Innovation: Vislink and MotoGP™

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025

Business Wire

a year ago

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025

Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases

Business Wire

a year ago

Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases

Origin Agritech Reports Fiscal Year End 2023 Results

PR Newswire

a year ago

Origin Agritech Reports Fiscal Year End 2023 Results

Bionomics to Present at Biotech Showcase™ 2024

GlobeNewswire

a year ago

Bionomics to Present at Biotech Showcase™ 2024

BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders

GlobeNewswire

a year ago

BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders

11 Popular Penny Stocks on Robinhood

Insider Monkey

a year ago

11 Popular Penny Stocks on Robinhood

Rubicon Technologies, Inc. 2023 in Review: A Year of Strategic Growth, Progress Toward Profitability, and Technology Leadership

Business Wire

a year ago

Rubicon Technologies, Inc. 2023 in Review: A Year of Strategic Growth, Progress Toward Profitability, and Technology Leadership

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

GlobeNewswire

a year ago

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

NewMediaWire

a year ago

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

Simply Wall St.

a year ago

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

Simply Wall St.

a year ago

One G. Willi-Food International Insider Raised Stake By 15% In Previous Year

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders

GlobeNewswire

a year ago

Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

InvestorPlace

a year ago

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

GlobeNewswire

a year ago

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment Webinar

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards

Business Wire

a year ago

SatixFy Receives NYSE American Notice of Non-compliance with Continued Listing Standards

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to January 3, 2024

GlobeNewswire

a year ago

Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to January 3, 2024

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets

GlobeNewswire

2 years ago

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets

uCloudlink Group Inc. (NASDAQ:UCL) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

uCloudlink Group Inc. (NASDAQ:UCL) Q3 2023 Earnings Call Transcript

Alumni Ventures Double Leads With Marin’s Budget Optimization

Business Wire

2 years ago

Alumni Ventures Double Leads With Marin’s Budget Optimization

Associated Press Finance

2 years ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

PR Newswire

2 years ago

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023

GlobeNewswire

2 years ago

Sonder Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023

Business Wire

2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated

Zacks

2 years ago

Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated

NETSOL Technologies Announces Two UK-Based Financial Institutions Go Live with NETSOL’s API-Based Calculation Engine Flex

GlobeNewswire

2 years ago

NETSOL Technologies Announces Two UK-Based Financial Institutions Go Live with NETSOL’s API-Based Calculation Engine Flex

American Oncology Network’s Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 2024

GlobeNewswire

2 years ago

American Oncology Network’s Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 2024

Share on Social Networks: